Liventa Bioscience and Medline Form Advanced Wound Care Partnership

Placental-based wound coverings to reach VA and other health care providers treating chronic wounds

(February 12, 2014) - Liventa Bioscience (formerly AFCell Medical), the trusted innovator in living donor birth tissues to advance wound care healing, has joined forces with industry leader Medline Industries, Inc. to enter the U.S. wound care market. Read the complete press release.

AFcell Medical Changes Its Name to Liventa Bioscience

West Conshohocken, Pa – February 6, 2014 - AFcell Medical has announced that it will now operate under the name Liventa Bioscience, effective immediately. The new name is a derivation of the words “live” and “placenta” and better reflects the company’s mission to improve the lives of patients through its placental-based advanced biologic tissue forms. Read the complete

press release.

Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point–of-Service Orthopedic Care

Portable cold chain logistics allows longer shelf life for live tissue cells

Philadelphia/Lake Forest - February 5, 2014 - Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX)  today  announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa’s cell-based, advanced biologics tissue forms. Read the complete press release.

Liventa Bioscience

100 Four Falls Corporate Center, Suite 660

1001 Conshohocken State Road

West Conshohocken, PA 19428

©2014 Liventa Bioscience           Contact Us: dbuche@LiventaBio.com